Immunohistochemistry was used to evaluate the clinical significance of p-AKT expression in ESCC, and the results showed higher p-AKT nuclear expression in lymph node metastases when compared with primary carcinoma. The gene discussed is AKT1; the disease is esophageal squamous cell carcinoma.